Pfizer Drops $118 Billion AstraZeneca Bid As Time Runs Out
Pfizer Inc. said Monday it will no longer pursue its sweetened £69.4 billion ($118 billion) offer for rival drug maker AstraZeneca plc, which kept up its stiff opposition to the bid even...To view the full article, register now.
Already a subscriber? Click here to view full article